Delivery Order SPE2DR25D1100-SPE2DR26FCU6D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,164.65 to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This is a firm fixed-price delivery order issued on December 8, 2025, with an ultimate completion date of December 30, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,422.32 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectables. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to support federal medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injections, with a ceiling value of $60,501.60 and completion target of December 16, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $19,759.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. This competitive award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,807.44 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL injectable medication. The contract utilizes firm fixed-price pricing with a completion date of October 15, 2025, and carries no set-aside designation, indicating competitive award to this qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a $5,918.93 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injections, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The contract will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $31,614.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. The contract, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This firm fixed-price delivery order, valued at $11,233.02, represents a non-competitive child award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion blanket agreement running through December 2026. The product will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,837.88 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 90 mg/0.3 ml pharmaceutical product. The contract was competitively awarded without set-aside designation and is structured as a firm fixed price delivery order, with an ultimate completion date of December 10, 2025. The award was issued on November 18, 2025, and performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,823.25 on November 24, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml under firm fixed price terms. The contract, which will be completed by December 16, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. This award was competitively awarded with no...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU6DDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $24,987.96 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 mL injectable medication. The contract is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, and was awarded on December 12, 2025, without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under the company's existing contractual relationships with the DLA. This award is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. Somatuline Depot, a long-acting somatostatin analog used for acromegaly and neuroendocrine tumor management, is consistent with the specialized pharmaceutical products provided through this prime vendor contract to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 12/11/25 |